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Abstract
Background: The use of neuromuscular blocking agents has previously been suggested to facilitate the dissection
of the latissimus dorsi muscle during breast reconstructive surgery. The aim of this study was to quantify the
influence of deep muscle relaxation on the force required to lift the latissimus dorsi muscle during flap preparation.
Methods: After ethics approval and written informed consent 15 patients scheduled for elective breast reconstruction
with a latissimus dorsi pedicled flap (muscle flap, not myocutaneous flap) under general anaesthesia were
prospectively included. Midway through the muscle dissection a sterile cotton tape was slung around the mid portion
of the muscle and connected with a sterile strain gauge stably positioned just above the patient. Thereafter, the
muscle was lifted by moving the strain gauge vertically upwards until a muscle tension similar to that created manually
during muscle dissection was achieved. The force (N) and distance required to tension the muscle were recorded and
the tension released. In a randomized and blinded crossover design either rocuronium (0.6 mg.kg-1) or normal saline
were given intravenously, and the tension protocol was repeated 2 min after each drug administration.
Results: Muscle relaxation significantly reduced the force for flap tensioning (median [percentiles] – 22 [-32/-13]
%; P = 0.011) in 10/15 patients. However, in the remaining 5 patients no significant effect was measured.
Normal saline had no effect on the measured force.
Conclusions: Deep muscle relaxation significantly reduces the force required to manually elevate the
latissimus dorsi muscle during its dissection in the majority of but not all patients.
Trial registration: The study was retrospectively registered on [17.6.2014] with the Australian and New
Zealand Clinical Trials Registry. ACTRN12614000637640
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Background
Deep neuromuscular block has recently been found to
be of potential use during various forms of general sur-
gery [1]. However, the usefulness of neuromuscular
blocking agents (NMBA) for plastic and reconstructive
surgery has not yet been formally investigated.
Nonetheless, after identification of the neurovascular
bundle, NMBA have been suggested to facilitate the dissec-
tion of the latissimus dorsi (LD) muscle for breast recon-
structive surgery [2]. Potential benefits of muscle relaxation
may be the “softer” muscle requiring less manual force
when raising the flap, hence facilitating dissection, as well
as the absence of strong, irritating muscle twitches during
electrocoagulation [3, 4].
However, the actual effect of NMBA on the tension of
the LD muscle has never been investigated. Therefore, it
was aim of this study to investigate the influence of deep
muscle relaxation on the manual force required during
muscle dissection.
Methods
After institutional review board approval (Royal Perth
Hospital Ethics Committee EC 2012/060) patients
scheduled for elective breast reconstructive surgery with
a pedicled LD flap were screened for eligibility. The
study was entered into the Australian and New Zealand
Clinical Trials Registry (ANZCTR) under the registra-
tion number ACTRN12614000637640. A CONSORT
flow chart is depicted in Fig. 1.
Included were female patients with elective LD sur-
gery, American Society of Anesthesiology (ASA) physical
status 1–3, age > 18 years, undergoing the procedure
under sevoflurane/opioid/rocuronium general anaesthe-
sia at the Royal Perth Hospital. Written informed con-
sent was obtained from all participating patients.
Excluded were patients < 18 years, the incapacity to con-
sent, a known allergy to the muscle relaxant rocuronium,
as well as any medication or comorbidity known or sus-
pected to interact with NMBA pharmacodynamics or the
assessment thereof (i.e. myopathy, history of a stroke).
Study protocol: After induction of anaesthesia with
propofol 2–3 mg.kg-1, fentanyl 1–3 mcg.kg-1 and
muscle relaxation with rocuronium (maximum
0.4 mg.kg-1) patients were tracheally intubated. Anaes-
thesia was maintained with sevoflurane to achieve a
standardized depth of anaesthesia (state entropy 40–
60). To monitor the depth of muscle relaxation (either
to confirm a state of non-paralysis or deep paralysis
during the time course of the study), a kinemyometric
(KMG monitor, GE Healthcare, Helsinki, Finland) de-
vice was used to measure neuromuscular transmission
from the ulnar nerve to the adductor pollicis brevis
muscle (supramaximal stimulation repeated every 15 s).
Non-paralysis was defined as a train of four (TOF) ratio
(TOFr) of > 95%, whereas deep paralysis was defined as
a post tetanic count (PTC) < 5 twitches (including a
profound bock with a PTC < 1).
The LD flap dissection was done with the patient in a
lateral (n = 13) or prone (n = 2) position. After raising
the mid-portion of the LD muscle leaving the origin
and insertion of the muscle intact, a sterile 1 cm wide
cotton tape was slung around the freed midportion of
the muscle to form a loose loop. This loop was then at-
tached via a 12 cm long sterile stainless steel rod with a
terminal hook to a commercially available strain gauge
(Force Gauge FG-5020; Lutron Electronic Enterprise;
Taipei; Taiwan). The latter was mounted on a stable
vertical stand with a horizontal arm, which was adjust-
able in height. This allowed positioning of the measure-
ment instrument just above the LD muscle (see Fig. 2).
At this time, non-paralysis of the patient was confirmed
(TOFr > 95%; see above) and the horizontal arm of the
instrument raised carefully in order to stretch and ten-
sion the muscle flap by raising it, hooked onto the cot-
ton sling, a few centimetres off its bed just enough to
mimic manual handling by the surgeon. The distance of
the muscle flap elevation (mm) as well as the required
force (N) were noted and the tension released there-
after. Following this “baseline” measurement, two more
assessments were made in 2 min intervals. Preceding
each, either normal saline (5 ml) or the muscle relaxant
rocuronium (0.6 mg.kg-1) were given by the attending
anaesthetist in random order (randomization envelope
containing the order of drug administration as deter-
mined by a randomly permuted block randomization
list opened by attending anaesthetist). To assess the
muscular tension after either muscle relaxant or pla-
cebo (saline), the muscle was lifted by the same dis-
tance used in the baseline assessment and the force
(Newton [N]) required were documented by a re-
searcher blinded to the drug administered. Further to
the assessment of forces, the (blinded to order of ad-
ministration) consultant surgeon in attendance was
asked to “guess” manually whether saline or muscle re-
laxant had been used. Three consultant surgeons were
overall involved in this non-standardized (no specific
scoring system used) assessment process.
At the end of the third measurement interval, all
patients had received saline as well as rocuronium
and were hence fully paralysed (confirmed by relaxo-
metric assessment as described above). This marked
the end of the study intervention and surgery as well
as anaesthesia proceeded as clinically required. At
the end of surgery, the TOF ratio was assessed and
reversal (TOFr > 90%) was achieved by the adm-
inistration of sugammadex (standard reversal agent
for amino-steroidal NMBA in our institution), as
appropriate.
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Statistics
The project was planned as a pilot investigation as to
our knowledge no related data exists. Therefore no for-
mal sample size calculation was done.
The primary outcome parameter was the force re-
quired to lift the LD flap for a pre-defined distance after
either rocuronium or saline (control) administration.
The secondary outcome parameter was the subjective
manual assessment (patient paralysed or not) by the at-
tending surgeon.
All data was tested for normal distribution (Shapiro-
Wilk test) and are displayed as appropriate (age, body
mass index (BMI) and distance of muscle lift: mean
(standard deviation); all other parameters: median (25%/
75% percentile; minimum and maximum value)). As the
related data was found to be non-normally distributed
(Shapiro-Wilk test) the Wilcoxon Signed Rank test was
used to compare the forces required to lift the LD muscle.
The original data are available on request from the
author.
Results
Data of 15 patients (52 (10) years, BMI 27 (6) kg.sqm2 -1)
were analysed. Data from all force assessments were
complete. However, in 3 patients the data from the surgi-
cal assessment of paralysis was missing due to a misunder-
standing during data collection.
Fig. 1 Consort flow diagram
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On average, the distance of LD muscle lift was 62
(20) mm with a required force (at baseline) of median
10 N (percentiles 6.6/13.8; minimum 2.6 N; maximum
18.6 N).
In the majority of cases (n = 10), administration of
rocuronium significantly decreased the required force
(median – 22 (percentiles -32/-13; minimum -8; max-
imum – 44) %; P = 0.011).
However, in a distinctively different group of five
patients (“non-responders”) the use of rocuronium did
not significantly change the median force required to
raise the LD muscle (median change of force after
rocuronium 1 (percentiles -5/+9; minimum 0; max-
imum 16) %).
By touching the LD muscle, the surgeon correctly
guessed whether muscle relaxant or placebo had been
administered in 10/12 patients (missing data in 3 pa-
tients). This was specifically interesting in the “non-re-
sponder” (= force required unchanged after muscle
relaxation) patients in whom the attending surgeon still
correctly guessed when the muscle relaxant had been
administered in 3/4 cases (1 incorrect guess; 5th case:
missing data).
Discussion
To the best of our knowledge this is the first study ever
objectively investigating the effect of a muscle relaxant
on an individual in vivo muscle relevant for plastic and
reconstructive surgery. We found that the administra-
tion of a muscle relaxant significantly reduced the force
likely required during manually raising the LD flap in
the majority (10/15) of patients. Correspondingly, the at-
tending surgeons subjectively felt a change (“softer
muscle”) in 83% of patients after muscle relaxant admin-
istration. Not formally investigated by this trial, but em-
pirically noted by surgeons during the investigation was
the absence of strong and irritating muscle twitches
when diathermy was used after the patient had been
paralysed. Above described changes support the claim
for a facilitating effect of muscle relaxants during LD
flap surgery [2–4].
Though this generally supports the use of muscle relax-
ation during pedicled LD flap surgery, the described effect
may not be required or even desired by every individual
surgeon. As NMBA such as rocuronium have rare but
potentially serious side effects, such as anaphylaxis [5], the
risk-benefit ratio of using muscle relaxants during LD
Fig. 2 Method of force measurement with strain gauge in-situ and mid-portion of flap lifted via a sterile cotton sling. [Figure drawn for the
authors by the Dept. of Medical Illustrations, Royal Perth Hospital]
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surgery is best discussed between surgeon and anaesthetist
for each individual patient.
Surgeons in our trial recognized the effects of muscle
relaxation vs saline in most patients, with an objective
reduction of force by means of muscle relaxation by a me-
dian of 22%. Though to our knowledge no similar study
exists, the magnitude of change is in-line with findings of
studies investigating the use of muscle relaxants for lap-
aroscopic surgery [6, 7]. After neuromuscular blockade,
Lindekaer et al. [6] found an increase of abdominal work-
space of approximately 9%. In a similar but larger pro-
spective trial Dubois et al. [7] could show that muscle
relaxation significantly improved surgical working condi-
tions. It is therefore likely, that surgeons would indeed feel
a difference of muscle tension in the range of 20%.
However, we were unable to measure a significant ef-
fect of muscle relaxation in 5/15 patients. Though the
attending surgeon still correctly guessed whether muscle
relaxant or placebo had been given in ¾ cases, we failed
to measure a change of required force in the “objective”,
strain gauge based, measurement. Initially, pre-operative
radiotherapy treatment was suspected to have potentially
caused a fibrous change in LD muscle tissue and pos-
sible scarring of the thoraco-dorsal neurovascular ped-
icle. However, though a post-hoc review of all patients
revealed pre-operative radiotherapy in five patients,
these did not turn out to be identical with the “non-re-
sponders” in the force assessment. All patients included
in this study were having secondary breast reconstruc-
tions—hence the differences (i.e. scarring) between pri-
mary vs. secondary augmentation did not apply and
cannot explain the group of non-responders. Further-
more, though 2 patients were operated in prone position
(resulting in a different, more “natural” elevation of the
LD muscle during measurements when compared to the
assessment in lateral position), 1 patient was found each
in the responder and non-responder group, respectively.
We are hence unable to explain the non-response to
muscle relaxation in a third of our patient. However, the
most convincing cause may have been an inadequate
mobilisation of the mid-portion of the muscle, resulting
in potential inaccuracies or a large skin paddle and over-
lying adipose tissue bundled in the loop. As non-
muscular tissue is not affected by muscle relaxation, the
measurement of force changes may have been impaired.
This would also explain the correct identification of
muscle relaxation in all but one “non-responders” by the
surgeon (surgeon touched the flap differently and may
have evaluated a wider area of muscle than that assessed
with the strain gauge).
This study has limitations: Firstly, only 15 patients were
recruited in the pilot project. However, in this context the
crossover design may add statistical power by eliminating
intra-individual patients’ differences as potentially biasing
factors. Secondly, though the strain gauge used was
commercially available and well validated, the setup of the
method of muscle tension assessment is new and has not
been formerly described. In the absence of previously
published similar investigations we opted to use a non-
invasive technique, which was seen to best mimic the
manual feeling of a surgeon during flap dissection while
providing the benefit of objective force assessment.
Conclusion
Within the limitations of a pilot study, this investigation
showed a significant reduction of objectively measured
force required during LD flap dissection after the use of
a neuromuscular blocking agent in the majority of
patients. Though this supports the use of such drugs
during LD flap surgery, the use of muscle relaxants
needs to be discussed between surgeon and anaesthetist
in each individual case.
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